Impact of Biochemical Failure Classification on Clinical Outcome: A Secondary Analysis of Radiation Therapy Oncology Group 9202 and 9413

BACKGROUND: Biochemical failure (BF) after radiation therapy is defined on the basis of a rising prostate-specific antigen (PSA) level (A1 failure) or any event that prompts the initiation of salvage androgen-deprivation therapy without PSA failure (A2). It was hypothesized that A2 failure may have...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Hamstra, Daniel A., Bae, Kyounghwa, Hanks, Gerald, Hu, Chen, Shipley, William U., Pan, Charlie C., Roach, Mack, Lawton, Colleen A., Sandler, Howard M.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4657945/
https://ncbi.nlm.nih.gov/pubmed/25410885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29146
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars